Cancer Immunotherapy Channeled via Remote Control

We’re a long way from controlling our immune systems as easily as we might change the channels on our televisions, but a new remote-control system, in the hands of clinicians, could enable the narrowcasting of immunotherapies. For example, cancer immunotherapies could be “switched on” in solid tumors and “switched off” in healthy tissues. The new remote-control system, then, could avoid the toxicities associated with the broadcasting of cancer immunotherapy througho